Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance

Novartis AGTrade
iShares 0 3 Month Treasury Bond ETFTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs iShares 0 3 Month Treasury Bond ETF — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while iShares 0 3 Month Treasury Bond ETF trades at $100.52. The key difference: Novartis AG pays a 3.07% dividend while iShares 0 3 Month Treasury Bond ETF pays none, and Novartis AG is trading nearer its 52-week high, iShares 0 3 Month Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.

NVSSGOV
Market Cap
$295.37B
Sector
HealthFixed Income
52-Week High
$168.62$100.74
52-Week Low
$119.31$100.28
Enterprise Value
$336.69B
Dividend Yield
3.07%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About iShares 0 3 Month Treasury Bond ETF

SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.

Read more on SGOV